SMA News TodayResearchers Discover Promising New Gene Therapy Approach for Spinal Muscular AtrophySMA News TodayThe iPSCs were then genetically modified to convert the SMN2 gene into a SMN1-like gene using the CRISPR/Cpf1 gene editing system. This syst… Continue reading
SMA News TodayResearchers Discover Promising New Gene Therapy Approach for Spinal Muscular AtrophySMA News TodayThe iPSCs were then genetically modified to convert the SMN2 gene into a SMN1-like gene using the CRISPR/Cpf1 gene editing system. This syst… Continue reading
Trending News Today: Pfizer Begins Trial for Duchenne Muscular Dystrophy Gene TherapySpecialty Pharmacy TimesPfizer has started a phase 1b trial for a Duchenne muscular dystrophy (DMD) gene therapy acquired as part of its $700 million takeover of Bambo… Continue reading
EurekAlert (press release) |
Sensor strategy a boon for synthetic biology
EurekAlert (press release) Rice University scientists who say biological sensors aren’t sensitive enough are doing something about it. The lab of synthetic biologist Jeffrey Tabor has introduced a new technique to dial up or down the sensitivity of two-component systems – a … |
|
FDA’s Regulation of Regenerative Medicine including Stem Cell Treatments, Tissue Engineering and Gene Therapies …
Business Wire (press release) This tutorial will provide an historical context for the use of stem cells in medicine, where the field has been and where it is going. It will also provide the few examples of FDA approved use of stem cells in medicine and what is needed for the field … |
Genetic Engineering & Biotechnology News |
CRISPR Combines with Gene Delivery System to Create Brain Tumor Model
Genetic Engineering & Biotechnology News Findings from the new study were published today in Nature Communications through an article entitled “Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling.” “A current high priority in cancer research is to … CRISPR From ‘Rampage’ Is Real & Its Effects Could Be Even More Terrifying Than In The MovieBustle Genome Engineering Market to Surpass US$ 8512.5 Mn Threshold by 2025MENAFN.COM |
Zacks.com |
Novartis to expand gene therapy pipeline with acquisition of AveXis for $8.7 billion
Chemical & Engineering News Novartis plans to acquire the neurological gene therapy firm AveXis for $8.7 billion. The purchase will bolster the Swiss giant’s standing as a big pharma leader in the emerging gene therapy field. AveXis’s leading drug candidate is its gene therapy to … Gene Therapy in Limelight on Novartis Deal: 3 Stocks in FocusZacks.com GSK Signs Strategic Agreement To Transfer Rare Disease Gene …Clinical Leader Orchard Therapeutics to buy GSK’s rare disease gene therapy portfolioPharmaceutical Business Review Nasdaq –Hospital Healthcare Europe –Pharmaceuticals News all 14 news articles » |